Navigation Links
NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
Date:2/13/2008

COEUR D'ALENE, Idaho, Feb. 13 /PRNewswire-FirstCall/ -- NightHawk Radiology Holdings, Inc. (Nasdaq: NHWK), the leading provider of radiology solutions to radiology groups across the United States, today announced financial results for its fourth quarter and full year ended December 31, 2007.

2007 Highlights

-- Full year revenues grew 65% to $151.7 million from $92.2 million for

the full-year 2006. Organic revenue grew $21.4 million, or 23%

year-over-year, while acquisitions contributed an additional

$38.1 million of revenue for the full year.

-- New service offerings represented 15% of total revenue, or

$22.4 million, including final interpretations at 8% of total revenue,

or $12.1 million, and business services at 7% of total revenue, or

$9.9 million.

-- The company completed and integrated three acquisitions: Teleradiology

Diagnostic Service, Inc. (TDS) in February, Radlinx Group, Ltd. in

April, and Midwest Physician Services, LLC in July. Through these

acquisitions, NightHawk increased its market share and the number of

affiliated radiologists providing professional interpretations, and

expanded its service offerings to include business services such as

revenue cycle management, accounting and financial management, and

transcription and records management. NightHawk provides the broadest

suite of integrated radiology solutions available.

-- The company ended the year providing services to nearly 1,500 sites,

representing approximately 26% of all hospitals in the United States.

-- Importantly, the company achieved 33% adjusted EBITDA margins for the

29,878

Change in fair value of

redeemable preferred

stock conversion

feature

Total other income

(expense) (1,561,904) 1,029,169

Income (loss) before

income taxes 4,565,107 3,659,149

Income tax expense 1,504,757 1,452,181

Net income (loss) 3,060,350 2,206,968

Redeemable preferred stock

accretion

Income (loss) applicable to

common stockholders $3,060,350 $2,206,968

Earnings (loss) per common

share:

Basic $0.10 $0.07

Diluted $0.10 $0.07

Weighted averages of common shares

outstanding:

Basic 30,260,996 29,912,134

Diluted 31,319,605 30,817,311

Year Ended December 31,

2007 2006

Service revenue $151,662,042 $92,168,246

Operating costs and expenses:

Professional services

(includes non-cash

compensation expense of

$862,328, $1,553,248,

$4,429,358 and $4,886,678) 63,617,406 38,963,287

Sales, general, and

administrative (includes

non-cash compensation

expense of $4,758,207,

$412,943, $10,601,004

and $1,073,455) 54,018,090 27,607,317

Depreciation and amortization 7,899,256 2,198,714

Total operating costs

and expenses 125,534,752 68,769,318

Operating income 26,127,290 23,398,928

Other income

(expense):

Interest expense (5,885,511) (562,221)

Interest income 3,130,335 3,027,917

Other, net (62,916) (34,258)

Change in fair value of

redeemable preferred

stock conversion

feature (44,183,770)

Total other income

(expense) (2,818,092) (41,752,332)

Income (loss) before

income taxes 23,309,198 (18,353,404)

Income tax expense 8,615,352 10,047,713

Net income (loss) 14,693,846 (28,401,117)

Redeemable preferred stock

accretion (117,534)

Income (loss) applicable to

common stockholders $14,693,846 $(28,518,651)

Earnings (loss) per common

share:

Basic $0.49 $(1.00)

Diluted $0.47 $(1.00)

Weighted averages of common shares

outstanding:

Basic 30,083,080 28,528,079

Diluted 31,083,971 28,528,079

NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

RECONCILIATION BETWEEN GAAP AND ADJUSTED NET INCOME

Three Months Ended

December 31, 2007

GAAP Adjustments As Adjusted

Service revenue $42,706,085 $42,706,085

Operating costs and expenses:

Professional services (includes

stock compensation expense of

$862,328 and $1,553,248 and

IBNR reserve of ($410,924)

and $2,000,000) 16,773,144 (451,404) 16,321,740

Sales, general, and

administrative (includes stock

compensation expense of

$4,758,207 and $412,943

and one time legal cost of

$477,862, and $0) 17,157,481 (5,236,069) 11,921,412

Depreciation and amortization 2,648,449 (1,810,734) 837,715

Total operating costs

and expenses 36,579,074 (7,498,207) 29,080,867

Operating income 6,127,011 7,498,207 13,625,218

Other income (expense):

Interest expense (2,220,769) (2,220,769)

Interest income 662,186 662,186

Other, net (3,321) (3,321)

Change in fair value of

redeemable preferred stock

conversion feature

Total other income

(expense) (1,561,904) (1,561,904)

Income before income

taxes 4,565,107 7,498,207 12,063,314

Income tax expense 1,504,757 2,465,861 3,970,618

Net income 3,060,350 5,032,346 8,092,696

Redeemable preferred stock accretion

Income applicable to common

stockholders $3,060,350 $5,032,346 $8,092,696

Earnings per share:

Basic $0.10 $0.27

Diluted $0.10 $0.26

Weighted average shares

outstanding:

Basic 30,260,996 30,260,996

Diluted 31,319,605 31,319,605

Three Months Ended

December 31, 2006

GAAP Adjustments As Adjusted

Service revenue $24,093,585 $24,093,585

Operating costs and expenses:

Professional services (includes

stock compensation expense of

$862,328 and $1,553,248 and

IBNR reserve $12,462,455

of ($410,924) and $2,000,000) $12,462,455 (3,553,248) 8,909,207

Sales, general, and

administrative (includes stock

compensation expense of

$4,758,207 and $412,943

and one time legal cost of

$477,862, and $0) 8,382,875 (412,943) 7,969,932

Depreciation and amortization 618,275 (117,042) 501,233

Total operating costs

and expenses 21,463,605 (4,083,233) 17,380,372

Operating income 2,629,980 4,083,233 6,713,213

Other income (expense):

Interest expense (1,950) (1,950)

Interest income 1,001,241 1,001,241

Other, net 29,878 29,878

Change in fair value of

redeemable preferred stock

conversion feature

Total other income

(expense) 1,029,169 1,029,169

Income before income

taxes 3,659,149 4,083,233 7,742,382

Income tax expense 1,452,181 1,592,461 3,044,642

Net income 2,206,968 2,490,772 4,697,740

Redeemable preferred stock accretion

Income applicable to common

stockholders $2,206,968 $2,490,772 $4,697,740

Earnings per share:

Basic $0.07 $0.16

Diluted $0.07 $0.15

Weighted average shares

outstanding:

Basic 29,912,134 29,912,134

Diluted 30,817,311 30,817,311

NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

RECONCILIATION BETWEEN GAAP AND ADJUSTED NET INCOME (LOSS)

Year Ended

December 31, 2007

GAAP Adjustments As Adjusted

Service revenue $151,662,042 $151,662,042

Operating costs and expenses:

Professional services

(includes stock compensation

expense of $4,429,358 and

$4,886,678 and IBNR reserve

of $1,038,000 and $2,000,000) 63,617,406 (5,467,358) 58,150,048

Sales, general, and

administrative (includes

stock compensation expense

of $10,601,004 and

$1,073,455 and one time

legal cost of $477,862

and $0) 54,018,090 (11,078,866) 42,939,224

Depreciation and amortization 7,899,256 (5,029,754) 2,869,502

Total operating

costs and expenses 125,534,752 (21,575,978) 103,958,774

Operating income 26,127,290 21,575,978 47,703,268

Other income (expense):

Interest expense (5,885,511) (5,885,511)

Interest income 3,130,335 3,130,335

Other, net (62,916) (62,916)

Change in fair value of

redeemable preferred stock

conversion feature

Total other income

(expense) (2,818,092) (2,818,092)

Income (loss)

before income taxes 23,309,198 21,575,978 44,885,176

Income tax expense 8,615,352 7,983,112 16,598,464

Net income (loss) 14,693,846 13,592,866 28,286,712

Redeemable preferred stock

accretion

Income (loss) applicable to

common stockholders $14,693,846 $13,592,866 $28,286,712

Earnings (loss) per share:

Basic $0.49 $0.94

Diluted $0.47 $0.91

Weighted average shares

outstanding:

Basic 30,083,080 30,083,080

Diluted 31,083,971 31,083,971

Year Ended

December 31, 2006

GAAP Adjustments As Adjusted

Service revenue $92,168,246 $92,168,246

Operating costs and expenses:

Professional services

(includes stock compensation

expense of $4,429,358 and

$4,886,678 and IBNR reserve

of $1,038,000 and $2,000,000) $38,963,287 (6,886,678) 32,076,609

Sales, general, and

administrative (includes

stock compensation expense

of $10,601,004 and

$1,073,455 and one time

legal cost of $477,862

and $0) 27,607,317 (1,073,455) 26,533,862

Depreciation and amortization 2,198,714 (508,875) 1,689,839

Total operating

costs and expenses 68,769,318 (8,469,008) 60,300,310

Operating income 23,398,928 8,469,008 31,867,936

Other income (expense):

Interest expense (562,221) (562,221)

Interest income 3,027,917 3,027,917

Other, net (34,258) (34,258)

Change in fair value of

redeemable preferred stock

conversion feature (44,183,770) 44,183,770

Total other income

(expense) (41,752,332) 44,183,770 2,431,438

Income (loss) before

income taxes (18,353,404) 52,652,778 34,299,374

Income tax expense 10,047,713 3,302,913 13,350,626

Net income (loss) (28,401,117) 49,349,865 20,948,748

Redeemable preferred stock

accretion (117,534) 117,534

Income (loss) applicable to

common stockholders $(28,518,651) $49,467,399 $20,948,748

Earnings (loss) per share:

Basic $(1.00) $0.73

Diluted $(1.00) $0.70

Weighted average shares

outstanding:

Basic 28,528,079 28,528,079

Diluted 28,528,079 29,988,558

NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES

RECONCILIATION BETWEEN NET INCOME AND ADJUSTED EBITDA

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Net income (loss) $3,060,350 $2,206,968 $14,693,846 $(28,518,651)

Interest expense

(income) 1,558,583 (999,291) 2,755,176 (2,465,696)

Income tax expense 1,504,757 1,452,181 8,615,352 10,047,713

Depreciation and

amortization 2,648,449 618,275 7,899,256 2,198,714

EBITDA 8,772,139 3,278,133 33,963,630 (18,737,920)

Stock compensation

expense 5,620,535 1,966,191 15,030,362 5,960,133

IBNR reserve (410,924) 2,000,000 1,038,000 2,000,000

One time legal cost 477,862 477,862

Change in fair

value of redeemable

preferred stock

conversion feature 44,183,770

Redeemable

preferred stock

accretion 117,534

Adjusted EBITDA $14,459,612 $7,244,324 $50,509,854 $33,523,517

NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES

HISTORICAL VOLUMES

Growth Rates Acquisition Contribution -

Total Year First 12 months

Quarter Year Volumes Sequential over Year DayHawk ATN TDS Radlinx

Q1 2004 120,554 36% 210% - - - -

Q2 2004 152,640 27% 178% - - - -

Q3 2004 182,737 20% 133% - - - -

Q4 2004 193,883 6% 119% 8,316 - - -

FY 2004 649,814 149% 149%

Q1 2005 222,341 15% 84% 15,850 - - -

Q2 2005 266,023 20% 74% 17,355 - - -

Q3 2005 298,759 12% 63% 18,905 - - -

Q4 2005 328,815 10% 70% 8,480 29,640 - -

FY 2005 1,115,938 72% 72%

Q1 2006 364,155 11% 64% - 32,130 - -

Q2 2006 417,269 15% 57% - 32,622 - -

Q3 2006 463,028 11% 55% - 32,086 - -

Q4 2006 448,084 (3%) 36% - - - -

FY 2006 1,692,536 52% 52%

Q1 2007 484,477 8% 33% - - 27,089 -

Q2 2007 731,418 51% 75% - - 51,095 137,611

Q3 2007 787,673 8% 70% - - 52,708 143,339

Q4 2007 730,992 (7%) 63% - - 51,644 124,394

FY 2007 2,734,560 62% 62%

full year (excluding the effects of non-cash IBNR malpractice reserves,

stock compensation, and a one-time charge related to the settlement of

an acquisition-related legal dispute) while investing in both

infrastructure and new services. As previously reported, the company

also incurred higher short-term expense in 2007 related to the

integration of various acquisitions.

"We accomplished a great deal in 2007," said Dr. Paul Berger, Chairman and Chief Executive Officer. "Our continued growth and profitability in this highly dynamic industry demonstrates the value and quality of our services and the success of our business model. Customers rely on NightHawk to meet their current and future needs with our advanced and innovative solutions, and our affiliated radiologists are some of the most productive in the world. We have made important investments in 2007 in new services, acquisitions and infrastructure. These items, combined with strong industry fundamentals, will enable NightHawk to continue growing rapidly while leading the transformation of the practice of radiology."

Full-Year Results

-- Full-year revenue grew 65% to $151.7 million from $92.2 million for the

full-year 2006. Full-year scan volumes grew 62% to 2.7 million, scans

compared with 1.7 million scans in 2006.

-- Organic revenue and organic scan volumes grew 23% and 27%,

respectively, year-over-year.

-- New service offerings, including daytime final and subspecialty reads,

cardiac 3D reconstructions and interpretations, and business services,

represented 15% of total revenue for the year. Final interpretations

comprised approximately 8% of revenue.

-- Adjusted net income grew 35% to $28.3 million, or $0.91 per diluted

share, from $20.9 million, or $0.70 per diluted share in the prior

year. The company's adjusted net income excludes certain non-cash

charges, including stock compensation, IBNR reserve and the

amortization of intangibles associated with acquisitions. Also excluded

from the calculation of 2007 adjusted earnings per diluted share is a

one-time charge of approximately $0.5 million related to the settlement

of an acquisition-related legal dispute with a former advisor.

-- GAAP net income was $14.7 million, or $0.47 per diluted share, compared

to ($28.5) million, or ($1.00) per diluted share in the same period of

2006. GAAP net income was impacted by higher non-cash charges for stock

compensation, IBNR, and amortization of intangibles and, in 2006, a

pre-IPO non cash expense related to the company's then outstanding

preferred stock.

-- The company's 2007 results were impacted by slightly lower fourth

quarter scan volumes due to greater than expected seasonality and a

delay in transitioning the former Radlinx physician contracts to the

company's compensation model to late in the fourth quarter.

Fourth-Quarter Results

-- Fourth quarter 2007 revenue grew 77% to $42.7 million from

$24.1 million in the fourth quarter 2006. Fourth quarter 2007 scan

volumes grew 63% to 730,992 scans compared with 448,084 scans in the

fourth quarter 2006.

-- Fourth quarter organic revenue and organic scan volume grew 19% and

24%, respectively, year-over-year.

-- New service offerings, primarily daytime final reads and business

services, represented 21%, or $8.8 million, of total revenue for the

quarter.

-- Adjusted net income for the fourth quarter of 2007 grew 72% to

$8.1 million, or $0.26 per diluted share, from $4.7 million, or

$0.15 per diluted share in the fourth quarter 2006.

-- GAAP net income grew 41% to $3.1 million, or $0.10 per diluted share,

compared to $2.2 million, or $0.07 per diluted share in the fourth

quarter 2006.

"NightHawk has strong operating fundamentals and the largest market share in what continues to be a high-growth, dynamic market. Going forward, the company seeks to better execute on the opportunities before us as we expand our business model," said Dr. Berger.

Updated Full-Year 2008 Guidance

The company updated its full-year 2008 guidance for revenue and adjusted earnings per diluted share. Full year 2008 revenue is now projected to be in the range of $195-$205 million, and adjusted earnings per diluted share is projected to be in the range of $1.10-$1.20.

"Our business continues to remain fundamentally strong, and we are pleased with our continued organic growth, our success at integrating acquisitions, and the traction we've achieved with our new service offerings. NightHawk has the leading market presence, a scalable business with high operating margins and strong cash flows, and a brand that is synonymous with quality and service, leaving us well positioned to execute on our vision," said Dr. Berger.

Other News

The company announced the appointment of Mark Kleinschmidt as Senior Vice President of Sales. Kleinschmidt joined NightHawk through the company's acquisition of Midwest Physician Services, LLC, the business services division of St. Paul Radiology, in July 2007. As Senior Vice President of Sales, his responsibilities include leading the NightHawk sales organization, including hiring, managing, and training field sales reps; developing efficient sales processes; managing sales performance; developing sales strategies; and pursuing large deals and strategic partnerships. Kleinschmidt has been in the radiology industry for nearly 20 years. Prior to joining NightHawk, he had been the CEO of St. Paul Radiology for nine years. Prior to his role at St. Paul, Kleinschmidt spent many years as a consultant to radiologists and radiology groups.

Earnings Conference Call

The fourth quarter and full-year 2007 conference call will be held on Wednesday, February 13, 2008 at 4:30 p.m. (ET). A live webcast of the conference call, as well as a replay, will be available online on the company's corporate website at http://www.nighthawkrad.net. Participants can also access the call by dialing 800-240-4186 (within the United States and Canada) or 303-205-0055 (international callers). A replay of the call will be available approximately two hours after the call has ended and will be available until 11:59 p.m. (ET) on Thursday, March 6, 2008. To access the replay, dial 800-405-2236 (within the United States and Canada), or 303-590-3000 (international callers) and enter the conference ID number: 11107716.

About NightHawk

NightHawk Radiology (Nasdaq: NHWK), headquartered in Coeur d'Alene, Idaho, is leading the transformation of the practice of radiology by providing high-quality, cost-effective services to radiology groups and hospitals throughout the United States. NightHawk provides the most complete suite of solutions, including professional services, business services, and its advanced, proprietary clinical workflow technology, all designed to increase efficiencies and improve the quality of patient care and the lives of physicians who provide it. NightHawk's team of U.S. board-certified, state-licensed, and hospital-privileged physicians located in the United States, Australia, and Switzerland, provides services 24 hours a day, seven days a week, to nearly 1,500 sites, representing approximately 26% of all hospitals in the United States. For more information, visit http://www.nighthawkrad.net.

Forward-Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the company's growth strategy, the expansion and market acceptance of its current service offerings, the future benefits of its acquisitions, and an outlook on the company's future financial results, including its revenue, and adjusted earnings per diluted share for 2008. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks associated with general economic conditions, competitive conditions in the radiology industry, and regulatory risks. Other factors that could cause operating and financial results to differ are described in the company's prospectus and periodic reports filed with the Securities and Exchange Commission (SEC). Other risks may be detailed from time to time in reports to be filed with the SEC. NightHawk does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.

Presentation of Non-GAAP Financial Information

The presentation of adjusted net income, adjusted EBITDA margins and adjusted earnings per diluted share are not measures of financial performance under GAAP and should not be considered a substitute for or superior to GAAP. Management believes these non-GAAP financial measures provide useful information to both management and investors by excluding certain expenses that may not be indicative of our core results and providing for consistency in financial reporting. Specifically, the company's non-GAAP adjusted net income measure, and related adjusted earnings per diluted share, described in this release exclude (i) for 2006 only, the non-cash charges related to the conversion feature and accretion of our preferred stock, which charges ceased upon the closing of our initial public offering when our shares of preferred stock converted into shares of common stock, (ii) the non-cash charges related to our stock-based compensation, (iii) the non-cash expense associated with the amortization of intangibles associated with acquisitions, (iv) the non-cash expense associated with changes to our IBNR reserve (incurred but not reported medical liability reserves) and (v) for 2007 only, a one-time charge of approximately $0.5 million related to the settlement of an acquisition related legal dispute with a former advisor . We exclude the non-cash charges related to our stock-based compensation due to the varying valuation methodologies, subjective assumptions and the variety of types of awards that companies can use when applying FAS 123R along with the fact that a substantial portion of our outstanding options and restricted stock units are held by our independent contractor physicians and require accounting treatment that differs from the accounting treatment for options and restricted stock units held by employees.

The company provides non-GAAP adjusted net income and related adjusted earnings per diluted share as financial measures because management believes these measures provide greater transparency with respect to information used by management in its financial and operational decision making and to enhance investors' overall understanding of our current financial performance and our future prospects. For reconciliation of our non-GAAP financial measures to the most applicable GAAP financial measure, please refer to the information included in the attached tables of this press release and on our corporate website under the heading investor relations.
"NHWKF"

NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

December 31, December 31,

ASSETS 2007 2006

Current assets:

Cash and cash equivalents $31,956,468 $46,500,818

Marketable securities 30,624,642 37,810,963

Trade accounts receivable, net 25,665,009 12,706,146

Deferred income taxes 655,124 365,930

Prepaids and other current assets 2,812,231 2,076,037

Total current assets 91,713,474 99,459,894

Property and equipment, net 10,554,913 6,192,541

Goodwill 68,601,360 4,913,844

Intangible assets, net 87,132,789 2,922,543

Deferred income taxes 1,251,113 2,480,972

Other assets, net 4,212,038 96,572

Total $263,465,687 $116,066,366

LIABILITIES

Current liabilities:

Accounts payable $6,071,513 $3,437,458

Accrued expenses 12,880,852 5,615,176

Accrued performance bonuses 2,106,610 1,024,891

Accrued payroll and related

benefits 2,462,813 1,359,107

Current portion of notes payable 1,000,000

Total current liabilities 24,521,788 11,436,632

Insurance reserve 3,038,000 2,000,000

Notes payable, less current portion 98,500,000

Other liabilities 2,717,185

Total liabilities 128,776,973 13,436,632

STOCKHOLDERS' EQUITY:

Common stock-150,000,000 shares

authorized; $.001 par value;

30,312,322 and 29,944,069 shares

issued and outstanding at

December 31, 2007 and December 31,

2006, respectively 30,312 29,944

Additional paid-in capital 249,273,581 230,116,635

Retained earnings (deficit) (112,957,598) (127,516,845)

Accumulated other comprehensive

income (deficit) (1,657,581)

Total stockholders' equity 134,688,714 102,629,734

Total $263,465,687 $116,066,366

NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

Three Months Ended

December 31,

2007 2006

Service revenue $42,706,085 $24,093,585

Operating costs and expenses:

Professional services

(includes non-cash

compensation expense of

$862,328, $1,553,248,

$4,429,358 and $4,886,678) 16,773,144 12,462,455

Sales, general, and

administrative (includes

non-cash compensation

expense of $4,758,207,

$412,943, $10,601,004

and $1,073,455) 17,157,481 8,382,875

Depreciation and amortization 2,648,449 618,275

Total operating costs

and expenses 36,579,074 21,463,605

Operating income 6,127,011 2,629,980

Other income

(expense):

Interest expense (2,220,769) (1,950)

Interest income 662,186 1,001,241

Other, net (3,321)
'/>"/>

SOURCE NightHawk Radiology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
2. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
3. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
4. NightHawk Radiology: One Source, One Solution
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
7. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. NightHawk Radiology exclusive radiology provider for high-risk plaque research initiative
9. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
10. AIUM CEO named among most influential in radiology
11. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... In the midst of making plans ... most important arrangement — planning a safe way of getting home after the festivities. ... Unfortunately, these celebrations often lead to drunk drivers on the roads who become involved ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Is the part ... Mother’s Day just a few days away, it’s a good opportunity to raise awareness ... to the American Academy of Dermatology, 40% of women experience hair loss or ‘thinning’ ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... for blood and service orders. Blood suppliers and their hospitals use BloodHub ... “BloodHub serves 13,000 active users across 2,100 hospitals who use our platform to ...
(Date:5/5/2016)... Wisconsin (PRWEB) , ... May 05, 2016 , ... ... proud to announce that Dr. Julie Lombardo, PT, DPT, MA, OCS, WCS, has ... of the WPTA Private Practice Award. The WPTA Private Practice Award is awarded ...
(Date:5/4/2016)... ... May 05, 2016 , ... The talus is the part ankle ... falls, or traffic accidents can cause the talus bone to be fractured, and a ... In a first-of-its-kind procedure using 3D printing technology, internationally renowned orthopedic surgeon Dr. ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... CITY, Mo. , May 3, 2016 /PRNewswire/ ... Kansas Medical Center,s Institute for Advancing Medical Innovation ... and commercialize new drugs, diagnostics and medical devices. ... provides BioNovus Innovations with rights to license, develop ... "This partnership represents ...
(Date:5/3/2016)... 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its ... http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... 2016 ACME Markets, ... Delaware County Councilman Dave White ... all ACME pharmacies across Delaware ... and Prevention (CDC), naloxone has saved 26,463 lives nationwide over the ... Delaware County were authorized to administer naloxone to ...
Breaking Medicine Technology: